Inovio Pharmaceuticals
INO
#8897
Rank
ยฃ0.10 B
Marketcap
ยฃ1.55
Share price
2.48%
Change (1 day)
-50.68%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ7.52 Million

According to Inovio Pharmaceuticals's latest financial reports the company's total debt is ยฃ7.52 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Inovio Pharmaceuticals - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ9.45 M-60.13%
2023-12-31ยฃ23.71 M-10.56%
2022-12-31ยฃ26.51 M8.37%
2021-12-31ยฃ24.46 M-14.6%
2020-12-31ยฃ28.64 M-62.25%
2019-12-31ยฃ75.88 M
2018-12-31N/A
2010-12-31N/A-100%
2009-12-31ยฃ7.48 M-9.39%
2008-12-31ยฃ8.26 M
2003-12-31ยฃ0.18 M1338.03%
2002-12-31ยฃ0.01 M-61.21%
2001-12-31ยฃ0.03 M
2001-03-31ยฃ0.08 M11.74%
2000-03-31ยฃ0.07 M19.96%
1999-03-31ยฃ0.06 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
ยฃ45.67 B 607,153.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ34.37 B 456,926.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
ยฃ0.26 B 3,423.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ24.03 B 319,474.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ31.05 B 412,805.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ17.91 B 238,038.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
ยฃ18.72 B 248,807.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA